A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Researchers detect cancer cells at an early stage of development via luminescent nanothermometers

   by Alice Chamberlain, Contributor    119    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

A recent study[1] undertaken at Rovira i Virgili University in Tarragona, Spain, reveals that biolabeling through luminescence thermometry has the potential to detect cancer cells at an early stage of development, just by monitoring the temperature rise in the body, due to accelerated metabolic activities in abnormal cells.

The Linkam THMS600 stage was used by researchers at the university to study the fluorescence of the nanoparticles that are produced. They used UV-Vis-NIR spectroscopy to characterise the nanomaterial’s emission spectra as a function of temperature, which then allowed them to use the catalogued emissions as in vitro luminescent nanothermometers. The observation of temperature-dependent luminescent particles for use as nanothermometers is made possible by the easy manipulation and chamber control provided by the THMS600, allowing for precise temperature and environmental control of with the ability to image the sample through a wide range of microscopic and spectroscopic techniques.

Duncan Stacey, Sales and Marketing Director at Linkam comments: “Our stages are perfectly suited for the analysis of temperature-sensitive materials such as these luminescent particles. They can be used in a range of applications, from biological samples to photovoltaics, where precise temperature accuracy and stability are required as well as the ability to image the sample through microscopy or spectroscopy. This is the case for the research undertaken at Rovira i Virgili University where a wide temperature range and pinpoint accuracy were necessary. Their work provides essential insight into the behaviour of temperature-responsive particles for cancer detection, and we are pleased to help enable such research.”

The researchers placed the sample on top of a boron nitride disk to aid with the uniform and fast distribution of temperature, ensuring that the entire sample is maintained at the same heat. Temperature stability and control is a critical aspect in the calibration of the development of the luminescent nanothermometers, hence the use of Linkam’s precision thermal control stages.


Joan Josep Carvajal Marti, Vice-dean of the Faculty of Chemistry at Rovira i Virgili University, Spain comments: “The use of the Linkam THMS600 stage allowed us, among other things, to develop luminescent thermometers operating in the different optical biological windows located in the near infrared part of the electromagnetic spectrum. This is where biological tissues are more transparent to the light, attaining deeper penetration depths which would allow the future treatment of diseases, such as cancer, through laparoscopic techniques.

We have also been able to develop thermochromic thermometers, in which the colour of the emission changes in accordance with the temperature, and that can be used as naked eye indicators as to whether industrial processes are progressing correctly or not.

The techniques using the THMS600 stage developed by the research team at Rovira i Virgili University enable, for the first time, the measurement of the thermal resistance of a nanoparticle. This is a milestone that opens up research into of the thermal properties of nanomaterials, allowing researchers to establish strategies to tailor these properties through the suitable design of the materials. The scientific breakthroughs by this group and others are contributing to the advancement of tools to detect, understand and treat cancer

ENDS

References

  1. Savchuk et al. Bifunctional Tm3+,Yb3+:GdVO4@SiO2 Core-Shell Nanoparticles in HeLa Cells: Upconversion Luminescence Nanothermometry in the First Biological Window and Biolabelling in the Visible. Available at: https://doi.org/10.3390/nano10050993

For more details about the Linkam THMS600 stage, visit: www.linkam.co.uk/thms600

Linkam Scientific Instruments Limited                                    The Scott Partnership  

8 Epsom Downs Metro Centre                                               1 Whiteside, Station Road 

Waterfield                                                                                Holmes Chapel 

Tadworth                                                                                 Cheshire CW4 8AA 

Surrey KT20 5LR                                                                    T +44 (0)1477 539539 

T +44 (0)1737 363476 

www.linkam.co.uk   

DuncanStacey@linkam.co.uk 

Twitter - @Linkamstages 

 

 

 

Share this:              
A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D
 

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *